| P50 | author | Alzheimer's Disease Neuroimaging Initiative | Q4738819 |
| | Michael W. Weiner | Q56850515 |
| | Niklas Mattsson | Q57012884 |
| | Timothy C Durazzo | Q91294764 |
| P2860 | cites work | Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study | Q47887017 |
| | The measurement of exhaled carbon monoxide in healthy smokers and non-smokers | Q47970092 |
| | Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking | Q48016618 |
| | Changing multiple health behaviors: smoking and exercise | Q48022478 |
| | Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). | Q48092766 |
| | Stroke and the risk of Alzheimer disease | Q48115889 |
| | Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders | Q48126851 |
| | Regional cerebral glutamate concentrations and chronic tobacco consumption | Q48194904 |
| | Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease | Q48266934 |
| | Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. | Q48276676 |
| | Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T. | Q48309009 |
| | In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress | Q48335247 |
| | Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain | Q48346710 |
| | Smoking and structural brain deficits: a volumetric MR investigation | Q48412093 |
| | Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease | Q48584697 |
| | Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history | Q48591536 |
| | Cytokines and alcohol. | Q48599806 |
| | Cigarette smoking behavior and respiratory alterations during sleep in a healthy population | Q48666024 |
| | Free radical production during ethanol intoxication, dependence, and withdrawal | Q48744575 |
| | Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years | Q48835886 |
| | Brain grey matter deficits in smokers: focus on the cerebellum | Q48905477 |
| | Smoking affects the phenotype of Alzheimer disease | Q48932230 |
| | MRI identification of early white matter injury in anoxic-ischemic encephalopathy | Q48974432 |
| | Effect of bacoside A on membrane-bound ATPases in the brain of rats exposed to cigarette smoke | Q49014189 |
| | Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction | Q49024592 |
| | Reduced Thickness of Medial Orbitofrontal Cortex in Smokers | Q49088764 |
| | Current cigarette smoking among adults - United States, 2011. | Q50117540 |
| | Smoking, dementia and cognitive decline in the elderly, a systematic review | Q21261847 |
| | Use of Florbetapir-PET for Imaging β-Amyloid Pathology | Q22253015 |
| | Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 |
| | Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation | Q24606390 |
| | Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area | Q24627871 |
| | Nicotine chemistry, metabolism, kinetics and biomarkers | Q24632647 |
| | Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T | Q24647560 |
| | Regulation of glutathione synthesis | Q24655260 |
| | Inflammation, mitochondria, and the inhibition of adult neurogenesis | Q26860239 |
| | Mild cognitive impairment and dementia: the importance of modifiable risk factors | Q26994975 |
| | Alzheimer's disease pathologic cascades: who comes first, what drives what | Q26995896 |
| | Cigarette prices in military retail: a review and proposal for advancing military health policy | Q27003986 |
| | Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 |
| | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| | Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: electron transfer and reactive oxygen species | Q28175442 |
| | The importance of glutathione in human disease | Q28180886 |
| | Smoking and the risk of hemorrhagic stroke in men | Q28195528 |
| | Differences between smokers and nonsmokers in regional gray matter volumes and densities | Q28237151 |
| | Hazardous compounds in tobacco smoke | Q28237162 |
| | The effects of tobacco smoke and nicotine on cognition and the brain | Q28240201 |
| | Glutathione | Q28261279 |
| | Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies | Q28306571 |
| | Reactive oxygen species, cellular redox systems, and apoptosis | Q28393669 |
| | Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 |
| | Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence | Q29393461 |
| | Oxidative stress and neurodegeneration: where are we now? | Q29617324 |
| | Injury of mouse brain mitochondria induced by cigarette smoke extract and effect of vitamin C on it in vitro. | Q44664661 |
| | Oxidation of glutathione and cysteine in human plasma associated with smoking | Q44696963 |
| | Emerging therapies for vascular dementia and vascular cognitive impairment | Q44787095 |
| | Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients | Q44790396 |
| | A 2-year follow-up study of cigarette smoking and risk of dementia | Q44828259 |
| | Ethanol can modify the effects of certain free radical-generating systems on astrocytes. | Q44853614 |
| | An 18-month follow-up study on the influence of smoking on blood antioxidant status of teenage girls in comparison with adult male smokers in Korea | Q44856460 |
| | Creatine kinase isoenzyme patterns upon chronic exposure to cigarette smoke: protective effect of Bacoside A. | Q45275587 |
| | Oxidative stress in the brain of nicotine-induced toxicity: protective role of Andrographis paniculata Nees and vitamin E. | Q46049587 |
| | Dose-dependent cigarette smoking-related inflammatory responses in healthy adults | Q46160003 |
| | Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation | Q46177751 |
| | Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia | Q46191441 |
| | Quantitative brain MRI in alcohol dependence: preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes | Q46550064 |
| | Protective effect of bacoside A on cigarette smoking-induced brain mitochondrial dysfunction in rats | Q46623716 |
| | Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. | Q46692906 |
| | Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors | Q46795217 |
| | Declining estimated prevalence of alcohol drinking and smoking among young adults nationally: artifacts of sample undercoverage? | Q46918492 |
| | Cigarette smoking induces heat shock protein 70 kDa expression and apoptosis in rat brain: Modulation by bacoside A. | Q46940323 |
| | Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline | Q47300836 |
| | Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease | Q47740675 |
| | Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. | Q50537933 |
| | The influence of smoking on the risk of Alzheimer's disease. | Q50644766 |
| | Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease. | Q50703088 |
| | Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. | Q50781974 |
| | Comparative study of pulmonary functions and oxidative stress in smokers and non-smokers. | Q50895156 |
| | Neurocognitive impairments in non-deprived smokers--results from a population-based multi-center study on smoking-related behavior. | Q50967418 |
| | Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice. | Q51019786 |
| | Subcellular localization of N-acetyl-aspartyl-glutamate, N-acetyl-glutamate and glutathione in brain | Q51160290 |
| | Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. | Q51869012 |
| | Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. | Q51939789 |
| | A comparison of neurocognitive function in nonsmoking and chronically smoking short-term abstinent alcoholics. | Q51979809 |
| | Chronic smoking is associated with differential neurocognitive recovery in abstinent alcoholic patients: a preliminary investigation. | Q51988218 |
| | Alzheimer's disease and smoking: bias in cohort studies. | Q53027429 |
| | Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. | Q53291345 |
| | Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study. | Q53312878 |
| | Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases | Q57279173 |
| | Influence of Apolipoprotein E Genotype on the Risk of Cognitive Deterioration in Moderate Drinkers and Smokers | Q57605974 |
| | Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study | Q57781910 |
| | Military exceptionalism or tobacco exceptionalism: how civilian health leaders' beliefs may impede military tobacco control efforts | Q59886772 |
| | Undertreatment of tobacco use relative to other chronic conditions. | Q64924124 |
| | Modulation of oxidant stress in vivo in chronic cigarette smokers | Q71884035 |
| | Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity | Q73192873 |
| | Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists | Q73383123 |
| | Vitamin C prevents cigarette smoke-induced oxidative damage in vivo | Q74297474 |
| | The pathological process underlying Alzheimer's disease in individuals under thirty | Q82953907 |
| | Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? | Q83656303 |
| | Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein | Q36417576 |
| | Interactive effects of chronic cigarette smoking and age on brain volumes in controls and alcohol-dependent individuals in early abstinence | Q36484347 |
| | Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology | Q36485712 |
| | Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. | Q36501617 |
| | Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms | Q36564840 |
| | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature | Q36575903 |
| | Why strong tobacco control measures "can't" be implemented in the U.S. Military: a qualitative analysis | Q36610643 |
| | Monitoring micronutrients in cigarette smokers | Q36625671 |
| | An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease | Q36650399 |
| | Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration | Q36711812 |
| | The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). | Q36729508 |
| | Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. | Q36759184 |
| | Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease | Q36788258 |
| | The projected effect of risk factor reduction on Alzheimer's disease prevalence | Q36825862 |
| | Effects of chronic alcohol dependence and chronic cigarette smoking on cerebral perfusion: a preliminary magnetic resonance study | Q36870251 |
| | The effects of chronic cigarette smoking on cognitive recovery during early abstinence from alcohol | Q36876260 |
| | The relationships of sociodemographic factors, medical, psychiatric, and substance-misuse co-morbidities to neurocognition in short-term abstinent alcohol-dependent individuals | Q37003483 |
| | Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease | Q37044978 |
| | Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults | Q37051726 |
| | Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging | Q37090048 |
| | Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods | Q37106026 |
| | The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury | Q37107765 |
| | Neurocognition in 1-month-abstinent treatment-seeking alcohol-dependent individuals: interactive effects of age and chronic cigarette smoking | Q37110256 |
| | Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression | Q37111515 |
| | Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. | Q37111598 |
| | Cigarette smoking and dementia: potential selection bias in the elderly | Q37139022 |
| | Effect of smoking and time on cognitive function in the elderly without dementia | Q37160197 |
| | Prostanoid and isoprostanoid pathways in atherogenesis | Q37178018 |
| | A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease | Q37254511 |
| | Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study | Q37310717 |
| | Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking | Q37311648 |
| | Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. | Q37377955 |
| | Interactive effects of chronic cigarette smoking and age on hippocampal volumes. | Q37409026 |
| | Glutathione: a key player in autoimmunity | Q37459164 |
| | Clinical and biomarker changes in dominantly inherited Alzheimer's disease | Q29619940 |
| | Propagation of tau pathology in a model of early Alzheimer's disease | Q29620203 |
| | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 |
| | How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways | Q30453328 |
| | Brain amyloid-β oligomers in ageing and Alzheimer's disease | Q30539133 |
| | Brain glutathione levels in patients with epilepsy measured by in vivo (1)H-MRS. | Q30664062 |
| | Neuroimaging as a marker of the onset and progression of Alzheimer's disease | Q30992217 |
| | Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism | Q33283916 |
| | Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials | Q33351611 |
| | (1)H MRS detection of glycine residue of reduced glutathione in vivo | Q33639213 |
| | Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. | Q33694502 |
| | APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging | Q33695738 |
| | Chronic cigarette smoking: implications for neurocognition and brain neurobiology | Q33765602 |
| | Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study. | Q33773477 |
| | Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease | Q33863598 |
| | Selective neuronal vulnerability to oxidative stress in the brain | Q33868370 |
| | Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). | Q33917702 |
| | Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease | Q33917722 |
| | In vivo brain imaging of human exposure to nicotine and tobacco | Q33946922 |
| | Brain atrophy and neuronal loss in alcoholism: a role for DNA damage? | Q33952947 |
| | Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations | Q33967016 |
| | Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study | Q33987747 |
| | Glutathione, oxidative stress and neurodegeneration | Q33994473 |
| | Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. | Q34039972 |
| | Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis | Q34112184 |
| | Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system. | Q34148796 |
| | Reimagining Alzheimer's disease--an age-based hypothesis | Q34155080 |
| | 24-month effect of smoking cessation on cognitive function and brain structure in later life | Q34161662 |
| | Mechanisms of neurodegeneration and regeneration in alcoholism | Q34169473 |
| | The association between smoking and Alzheimer's disease: effects of study design and bias | Q34169575 |
| | Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification | Q34183016 |
| | Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study | Q34192778 |
| | Smoking-related interstitial lung diseases: a concise review | Q34222060 |
| | Factors underlying prefrontal and insula structural alterations in smokers | Q34233349 |
| | Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study | Q37524511 |
| | Smoking, nicotine and neuropsychiatric disorders | Q37576485 |
| | Linking oxidative stress to inflammation: Toll-like receptors | Q37677270 |
| | The neurobiology of isoprostanes and Alzheimer's disease | Q37684187 |
| | A 2-process model for neuropathology of Alzheimer's disease | Q37688750 |
| | Review: sporadic cerebral amyloid angiopathy | Q37800132 |
| | Amyloid-independent mechanisms in Alzheimer's disease pathogenesis | Q37808579 |
| | Amyloid-dependent and amyloid-independent stages of Alzheimer disease | Q37863977 |
| | Risk factors and preventive interventions for Alzheimer disease: state of the science | Q37873674 |
| | Inflammation in the early stages of neurodegenerative pathology | Q37912590 |
| | From the field of play to the field of combat: a review of the pharmacological management of concussion | Q37979980 |
| | Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation. | Q38021272 |
| | Cognitive reserve in ageing and Alzheimer's disease. | Q38053269 |
| | The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 |
| | On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. | Q38102758 |
| | Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid | Q38113683 |
| | Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product? | Q38121221 |
| | Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 |
| | The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population | Q39746495 |
| | Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America | Q39763910 |
| | Smoking cessation and Alzheimer's disease: facts, fallacies and promise | Q40164691 |
| | Cigarette smoking and cardiovascular disease: lessons from framingham. | Q41413636 |
| | Classification, diagnosis and treatment of vascular dementia | Q41634583 |
| | Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. | Q41832548 |
| | Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains | Q41996786 |
| | Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study | Q42472041 |
| | Military risk factors for Alzheimer's disease | Q42606232 |
| | [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease | Q42712929 |
| | Organ-related cigarette smoke-induced oxidative stress is strain-dependent | Q43004168 |
| | Brain mitochondrial alterations after chronic alcohol consumption. | Q43179078 |
| | Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. | Q43199063 |
| | Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study | Q43202664 |
| | MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis | Q43288704 |
| | The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study | Q43420409 |
| | Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. | Q43516778 |
| | Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study | Q43570563 |
| | A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. | Q43577349 |
| | Hippocampal formation glucose metabolism and volume losses in MCI and AD. | Q43668221 |
| | Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). | Q44028807 |
| | Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins | Q44053638 |
| | Apolipoprotein E, neurodegeneration, and Alzheimer disease | Q44134152 |
| | Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat. | Q44226191 |
| | 21st-century hazards of smoking and benefits of cessation in the United States | Q44235905 |
| | Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea | Q44349701 |
| | Glutathione in cognitive function and neurodegeneration | Q44419551 |
| | Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. | Q44600343 |
| | F2-isoprostanes as markers of oxidative stress in vivo: an overview | Q36317981 |
| | Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake | Q36326890 |
| | Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking | Q36357389 |
| | Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats | Q34273687 |
| | The impact of chronic cigarette smoking on recovery from cortical gray matter perfusion deficits in alcohol dependence: longitudinal arterial spin labeling MRI | Q34284574 |
| | Measures of Learning, Memory and Processing Speed Accurately Predict Smoking Status in Short-term Abstinent Treatment-seeking Alcohol-dependent Individuals | Q34310791 |
| | Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats | Q34459726 |
| | The pathophysiology of cigarette smoking and cardiovascular disease: an update | Q34547935 |
| | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease | Q34606557 |
| | Health effects of tobacco use and exposure. | Q34617328 |
| | Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes | Q34624775 |
| | Nicotine and the adolescent brain: insights from an animal model | Q34636465 |
| | Mild oxidative stress induces redistribution of BACE1 in non-apoptotic conditions and promotes the amyloidogenic processing of Alzheimer's disease amyloid precursor protein | Q34684198 |
| | Mild cognitive impairment: ten years later | Q34847370 |
| | Tobacco smoking, harm reduction, and biomarkers | Q34931121 |
| | Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics | Q34988116 |
| | Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence | Q34990385 |
| | Early diagnosis of Alzheimer's disease: is MCI too late? | Q34992855 |
| | Cellular and synaptic mechanisms of nicotine addiction | Q35000325 |
| | Reduction in oxidatively generated DNA damage following smoking cessation | Q35014948 |
| | Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence | Q35065687 |
| | Glutathione pathways in the brain. | Q35129250 |
| | Influence of Smoking on Predictors of Vascular Disease | Q35562469 |
| | Accounting for bias due to selective attrition: the example of smoking and cognitive decline | Q35613141 |
| | A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers. | Q35673184 |
| | Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative | Q35676804 |
| | Military tobacco policies: the good, the bad, and the ugly | Q35767525 |
| | Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis | Q35789636 |
| | ApoE genotype accounts for the vast majority of AD risk and AD pathology | Q35789660 |
| | Alzheimer's disease and the amyloid cascade hypothesis: a critical review | Q35855587 |
| | Smoking, death, and Alzheimer disease: a case of competing risks | Q35874663 |
| | Alcohol, oxidative stress, and free radical damage | Q35947149 |
| | Genotoxicity of tobacco smoke and tobacco smoke condensate: a review | Q35968076 |
| | Dementia incidence continues to increase with age in the oldest old: the 90+ study | Q36066005 |
| | Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease | Q36081889 |
| | Role of inflammation in neurodegenerative diseases | Q36125754 |
| | EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE. | Q36241900 |
| P433 | issue | 3 Suppl | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | S122-45 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Alzheimer's and Dementia | Q15750965 |
| P1476 | title | Smoking and increased Alzheimer's disease risk: a review of potential mechanisms | |
| P478 | volume | 10 | |